Navigation Links
Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
Date:2/19/2009

mission.

Forward Looking Statement

Statements herein relating to future financial or business performance, conditions or strategies and other financial and business matters, including expectations regarding clinical developments, safety, efficacy and potency of our vaccines, and supply availability are forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including the failure by Novavax to secure and maintain relationships with collaborators; risks relating to the early stage of Novavax's product candidates under development; uncertainties relating to commencing clinical trials and their outcome; risks relating to the supply and commercialization, if any, of Novavax's proposed product candidates; dependence on the efforts of third parties; dependence on intellectual property; competition for clinical resources and patient enrolment from drug candidates in development by other companies with greater resources and visibility, and risks that we may lack the financial resources and access to capital to fund our operations. Further information on the factors and risks that could affect Novavax's business, financial conditions and results of operations, is contained in Novavax's filings with the U.S. Securities and Exchange Commission, which are available at http://www.sec.gov. These forward-looking statements speak only as of the date of this press release, and Novavax assumes no duty to update forward-looking statements.

Available Topic Expert(s): For information on the listed expert(s), click appropr
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
2. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
3. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
4. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
5. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
6. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
7. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
8. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
9. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
10. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... today they are expanding their reach nationally by providing customers with on-site 17025 accredited pipette calibrations. ... ... ... ... Photo - http://photos.prnewswire.com/prnh/20150601/219758 ...
(Date:6/2/2015)... 2015  CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached an agreement to settle ... Delaware Court of Chancery, which names as ... directors and officers, and names the Company as a ... re CytRx Corp. Stockholder Derivative Litigation , C.A. No. ...
(Date:6/2/2015)... ACTON, Mass. , June 2, 2015  Psychemedics ... global leader for over twenty-five years, announced the addition ... panels. In response to growing abuse concerns, the addition ... panel and D-Amphetamine/Adderall® was added as an option to ... , Chairman and CEO stated:  "Sadly, more and more ...
Breaking Medicine Technology:Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 3Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 4CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4Psychemedics Announces Addition Of FDA Cleared Drugs 2Psychemedics Announces Addition Of FDA Cleared Drugs 3
... Inc. (Nasdaq: BNVI ) announced today that it ... year 2010 ended September 30, 2010 on Thursday, November 11, ... to review the financial results on Thursday, November 11, 2010 ... the call by dialing (877) 317-6789 or (412) 317-6789, or ...
... 4, 2010 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ... Brian M. Culley, will present at the Wall Street Analyst ... 2010 at 12:50 p.m. Eastern time, at The University Club ... a live audio webcast and slide presentation on the Company,s ...
Cached Medicine Technology:
(Date:6/2/2015)... Branchburg, NJ (PRWEB) June 02, 2015 ... independent verification for non-GMO products made according to ... avoidance. Verified products are produced in compliance with ... testing of all GMO risk ingredients, facility inspections ... possible standards for GMO avoidance. , “Savoury Systems ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Consumer ... consumer organization, today announced its commitment to help ... to the use of antibiotics sicken about 2.25 ... to the Centers for Disease Control and Prevention. ... President and CEO Marta Tellado participating in the ...
(Date:6/2/2015)... June 02, 2015 Robert LaPrade, ... Officer at the Steadman Philippon Research Institute, participated in ... for Single Sport Specialization? ” This was a collaborative ... (AOSSM) Research Committee that was recently published in the ... this project was limited, there is evidence that early ...
(Date:6/2/2015)... While the movie box office may be ... books themselves are stepping into a new role: that ... produce educational comics in multiple languages that will explain ... - an international effort to address humanity’s most pressing ... energy, inequality, climate change and more. , “The United ...
(Date:6/2/2015)... North Vancouver, B.C., Canada (PRWEB) June 02, 2015 ... American publisher of audit, compliance and risk ... of a new online risk management effectiveness gap-improvement ... reduce the effect of uncertainty on objectives. Organizations ... but they improve their capabilities to do this ...
Breaking Medicine News(10 mins):Health News:Savoury Systems International Receives Non-GMO Project Verification Continuing its Commitment to Provide Customers with Clean Label Ingredients 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 3Health News:Early Single Sport Specialization May Put Youth Athletes at Risk for Overuse Injuries According to Colorado Knee Specialist Robert LaPrade, MD, PhD 2Health News:Early Single Sport Specialization May Put Youth Athletes at Risk for Overuse Injuries According to Colorado Knee Specialist Robert LaPrade, MD, PhD 3Health News:Can Comics Help the United Nations Save the World? 2Health News:Can Comics Help the United Nations Save the World? 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 4
... of an unfertilized egg or development of eggs from ... On! This is not all. Scientists have ... are made from a single egg, without the need ... parthenotes by taking donated eggs from women who were ...
... it is equally important to lose weight in a healthy ... whole grains and other such nutritious foods// seems tempting isn’t ... is more effective than the conventional diet regime. It is ... plant-based diet has been found to be more effective at ...
... a study by a researcher from University of California, ... are found not in the similarity of the genome ... them. ,Researcher had described genetic differences between the ... that is also expressed in brain cells associated with ...
... as over the counter drug with out medical prescription ... pregnancy. The decision was announced// by the Indian Health ... minister said, "The step has been taken to enable ... sexual exposure, contraceptive accident or forced sex," Dr. Suneeta ...
... the Steno Diabetes Center, Denmark has found that ... //antihypertensive drugs, reduced the chances of developing kidney ... in urine of these patients. ,Diabetes ... to kidney diseases. Supplementation of Spironolactone has found ...
... have died of it in the last three years. Unofficial estimates, ... more than 2,000 full-blown AIDS cases. The increase //in AIDS patients ... ,Jharkand plans to open condom booths in public places ... attempt to open the condom booths will help to educate people ...
Cached Medicine News:Health News:Weight loss accomplished by high carbohydrate, vegan diet 2Health News:Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug 2
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... tubes contain a buffered sodium ... with a citrate concentration of ... mol/l (3.8%). The mixing ratio ... to 9 parts blood. In ...
... Cross-match tubes are available ... serum tube contains a clotting ... cross-match tests where serum is ... EDTA cross-match tube is suitable ...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: